Tekmira May Name Third Drug Target, Aims to Release Data from Cholesterol Trial in 2010

While Tekmira had speculated that it could select its third target in 2009, the company’s top executive said that it remains focused on choosing “the right one [and that] … it may well be early next year before we decide which it is.”

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.